Alpha DNA Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Alpha DNA Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35	Closed	-$2K	–	829
2020 Q4	$2K	Buy	+35	New	+$1.83K	﹤0.01%	502

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Alpha DNA Investment Management's BEAT Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 35 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Alpha DNA Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 35 BioTelemetry, Inc. shares in Q1 2021, an estimated $2K.
Alpha DNA Investment Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Alpha DNA Investment Management's BioTelemetry, Inc. position peaked at $2K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.